Genialis - Crunchbase Company Profile & Funding

Q: Where is Genialis's headquarters?

Genialis is located in Boston, Massachusetts, United States.

Q: Who invested in Genialis?

Genialis has 9 investors including redalpine And P5 Health Ventures.

Q: When was the last funding round for Genialis?

Genialis closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Genialis raised to date?

Genialis has raised obfuscated.

Overview

Genialis

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

+2 more milestones

See more interactive data and historical milestones on desktop for the best experience

About Genialis

CB Rank

22657

Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform.

Founded

obfuscation

Private

Series A

Boston, Massachusetts, United States

11-50

www.genialis.com

Bioinformatics

Biotechnology

Health Care

Medical

Precision Medicine

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Rafael Rosengarten: CEO
Luka Ausec: Chief Discovery Officer

Details

Legal Name

Genialis, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Cedric Odje, Klemen Hrovat, Luka Ausec, Miha Stajdohar, Nejc Skoberne, Rafael Rosengarten

About the Company

Genialis is a computational precision medicines company that develops a clinical biomarker discovery platform. It engages in unraveling complex biology to find new ways to address disease. Its platform defines, models, and validates actionable biomarkers and optimally positions novel drugs to accelerate translational research and clinical

development.

Genialis was established in 2015 in Boston, Massachusetts by Rafael Rosengarten.

Phone Number

+1 617 237 0085

Contact Email

info@genialis.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Genialis™ Supermodel

An AI-driven computational model that predicts and explains therapeutic responses in cancer patients using RNA biomarker data.

ResponderID™

A patient classification biomarker that stratifies KRAS-mutated cancer patients by their clinical response to therapy.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A
obfuscated obfuscation	Series A - Genialis	6	obfuscated obfuscation	Debiopharm Innovation Fund, Taiwania Capital Management Corporation	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
redalpine	—	Series A - Genialis	—
redalpine	—	Series A - Genialis	—
redalpine	—	Series A - Genialis	—
redalpine	—	Series A - Genialis	—
redalpine	—	Series A - Genialis	—